Compound Detail
CHEMBL4458563
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
ClCc1ccc(C(C[n+]2ccn(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)c2)OCc2ccc(Cl)cc2Cl)c(Cl)c1
Basic Information
| ChEMBL ID | CHEMBL4458563 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QFAZWBSIQZNXKF-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
666.3
MW (Da)
10.38
ALogP
2
HBA
0
HBD
18.0
PSA (Ų)
0.11
QED
2
Ro5 Violations
10
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 4.74
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Eyes absent homolog 2 CHEMBL1293275 | IC50 | 4.74 | 4.74 | 18250.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Eyes absent homolog 2 | IC50 | = | 18250.0 | nM | 4.74 | Inhibition of GST-fused human Eya2 ED (253 to 538 residues) expressed in Escheri... | - |
Data from ChEMBL 36 via Core Engine